Disclosure of Voting results of AGM (Clause 35A)
Panacea Biotec Ltd has informed BSE regarding the details of Voting results at the 28th Annual General Meeting of the Company held on September 29, 2012, under Clause 35A. (For more details kindly refer Corporate Announcements on www.bseindia.com). Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
Ravinder Jain has submitted the disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011 Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Ravinder Jain has submitted the disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992 Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Soshil Kumar Jain, Karta of Soshil Kumar Jain HUF has submitted the disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992 Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
Ravinder Jain has submitted the disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 2011 Panacea Biotec Entered into Strategic Alliance with Osmotica Pharmaceutical
Panacea Biotec Ltd has informed BSE regarding a Press Release dated September 11, 2012, titled "Panacea Biotec Entered into Strategic Alliance with Osmotica Pharmaceutical". (For more details kindly refer Corporate Announcements on www.bseindia.com). Fixes Book Closure for AGM
Panacea Biotec Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2012 to September 29, 2012 (both days inclusive) for the purpose of 28th Annual General Meeting (AGM) of the Company to be held on September 29, 2012. Updates
Panacea Biotec Ltd has informed BSE that Credit Analysis & Research Ltd (CARE) has revised credit rating pertaining to Long Term Bank Facilities to 'CARE BB' (Double B) from 'CARE A-' (Single A Minus) and to 'CARE A4' (A Four) from 'CARE A2+' (A Two Plus) in regard to Short Term Bank Facilities.'CARE BB' (Double B) rating is applicable to instruments which are considered to have moderate risk of default regarding timely servicing of financial obligations.... Financial Results & Limited Review for June 30, 2012
Panacea Biotec Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended June 30, 2012. Outcome of Board Meeting
Panacea Biotec Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 17, 2012, inter alia, has not recommended any dividend on the Equity Shares of the Company for the financial year ended on March 31, 2012, in view of non-availability of profits.